visium spatial transcriptome (10X Genomics)
Structured Review

Visium Spatial Transcriptome, supplied by 10X Genomics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/visium+spatial+transcriptome/expression+gene+slides+spatial+visium/med_rxiv__64898__2026__05__13__26353128-63-1-4
Average 86 stars, based on 1 article reviews
Images
1) Product Images from "A phenotype-to-mechanism framework links phenome-wide comorbidity architecture to molecular mechanisms and therapeutic discovery in complex diseases"
Article Title: A phenotype-to-mechanism framework links phenome-wide comorbidity architecture to molecular mechanisms and therapeutic discovery in complex diseases
Journal: medRxiv
doi: 10.64898/2026.05.13.26353128
Figure Legend Snippet: ( a-b ) Uniform Manifold Approximation and Projection (UMAP) visualization of cell populations from single-cell RNA-seq of HS lesional and normal skin. We integrated the NYU dataset and two publicly available datasets containing normal skin samples (GSE173706 and GSE195452). Cell types were annotated using known marker genes. The UMAP plots are colored by cell types ( a ) and conditions, i.e., HS lesion vs. normal ( b ). ( c ) Comparisons of PiHSM module scores between HS lesions and normal controls across major cell populations. For each cell type, module scores were calculated based on the PiHSM genes that were expressed in ≥ 2% of cells and upregulated in HS lesional skins. ( d ) Heatmap of differentially expressed genes (HS lesion vs. normal) across cell types. Genes upregulated in HS are shown in red, and downregulated genes are shown in blue. *FDR < 0.05; **FDR < 0.01; ***FDR < 0.001. ( e-h ) We integrated two 10x Visium spatial transcriptomics including one normal axilla and one HS patient sample containing tunnel. Spatial feature plots for multiple genes are shown with the same expression scale. Corresponding immunofluorescence staining was performed to evaluate if the protein expression pattern matches its transcription ( f-h ). Designated proteins are visualized as red, with references of keratinocytes by K14 (green) and nuclei with DAPI staining (grey). Scale bars: 25 µm.
Techniques Used: Single Cell, RNA Sequencing, Marker, Spatial Transcriptomics, Expressing, Immunofluorescence, Staining
Related Articles
Microscopy:Article Title: A phenotype-to-mechanism framework links phenome-wide comorbidity architecture to molecular mechanisms and therapeutic discovery in complex diseases Article Snippet: .. Further, Quantitative Proteomics:Article Title: A phenotype-to-mechanism framework links phenome-wide comorbidity architecture to molecular mechanisms and therapeutic discovery in complex diseases Article Snippet: .. Further, Gene Expression:Article Title: DGSIST: Clustering spatial transcriptome data based on deep graph structure Infomax. Article Snippet: Although spatial transcriptomics data provide valuable insights into gene expression profiles and the spatial structure of tissues, most studies rely solely on gene expression information, underutilizing the spatial data.. To fully leverage the potential of spatial transcriptomics and graph neural networks, the DGSI (Deep Graph Structure Infomax) model is proposed.. This innovative graph data processing model uses graph convolutional neural networks and employs an unsupervised learning approach. |



![Comparative spatial multi-omics analysis of acute myeloid leukemia patients’ bone marrow and extramedullary tissues (A) Schematic representation of the study workflow. Paired bone marrow (BM) samples (BM1 and BM2) and extramedullary (EM) samples (EM1, from skin; and EM2, from lymph node) from 2 newly diagnosed patients with acute myeloid leukemia (AML) (PT1 and PT2) were fixed in formalin and embedded in paraffin (FFPE) and then sectioned for use in <t>Visium</t> assays (v1 and v2), and Opal multiplex fluorescent immunohistochemistry (mfIHC). The Visium spatial <t>transcriptomics</t> (ST) results were validated using GeoMx digital spatial profiling (DSP) with tissue microarrays (TMAs) of samples from 3 newly diagnosed patients with AML (PT3, PT4, and PT5). An additional 4 AML bone marrow samples that performed the Visium gene and protein expression assay are used as a validational cohort (PT6, PT7, PT8, and PT9). Image created with BioRender ( https://biorender.com ). (B) Uniform manifold approximation and projection (UMAP) plot showing our reference map consisted of 79,029 cells collected from 9 healthy BM donors and 7 patients with AML with diploid cytogenetics to match the patient cytogenetic profiles, and included both newly generated scRNA data and previous works. This map consisted of 21 cell types, including T cells (CD4 + and CD8 + naive, effector, and memory T cells, T regulatory [Treg] cells, and unconventional T cells), other immune cells (Natural killer [NK] cells, B cells and plasma cells), hematopoietic progenitors (Hematopoietic stem cells [HSCs], common lymphoid progenitors [CLPs], granulocyte-monocyte progenitors [GMPs]), myeloid cells (megakaryocytes/platelets, monocytes, early and late erythroid cells, conventional and plasmacytoid dendritic cells) and leukemic (AML) cell populations. (C) Immunohistochemical staining of CD11c, MPO, and CD3e on BM1 sections that were used for histopathological annotation. The scale bar for the main tissue panels represents 1 mm. The scale bar for the zoomed-in panels, corresponding to the boxed regions, represents 100 μm. (D) Unsupervised clustering and pathology annotation for the projected spatial map of BM1, revealing 3 distinct regions with an adjusted rand index (ARI) of 0.46. (E) Spatial deconvolution of BM1 tissue, showing erythroid and AML cell populations, with CD11c immunohistochemistry (IHC) overlaid on an image of hematoxylin and eosin (H&E)-staining. The dotted red lines represent regions enriched for the erythroid cell population; dotted black lines, regions enriched for the AML cell population; and solid lines, regions that overlapped with other tissue sections. (F) Heatmap of Z score normalized canonical markers in pathology annotations, with matching unsupervised cluster distributions represented as a pie chart. HBB, HBD, HBA2, GATA1/2 are erythroid genes and S100A12, FCGR3A, CD14, MS4A7, and , CD33 are monocyte/leukemic genes. (G) Representative overlay of Visium H&E staining with Opal mfIHC and the generated spot-level data for CD33, CD71, CXCL12, CXCR4, CD68, and IL-6. Boxes illustrate magnified regions showing concordance between transcript-level (Visium) and protein-level (Opal) signals at the spot level. (H) Phenotype staining on near-adjacent tissue sections for markers of leukemic (CD33), monocytic (CD68), and erythroid (CD71) populations. DAPI was used as a nuclear counterstain. The spatial distribution of these markers corroborates ST-based spot deconvolution. Scale bars: 1 mm (whole-slide panels) and 100 μm (selected region panels). (I) Box and spatial plots of mfIHC staining intensities for phenotypic markers across ST-defined clusters in BM1, highlighting the enrichment of leukemic and monocytic populations in cluster 3 and that of erythroid populations in cluster 2 at BM1. Scale bars: 1 mm (whole-slide panels) and 100 μm (selected region panels). ns, not significant. ∗∗∗∗ p < 0.0001, Wilcoxon rank-sum test.](https://pub-med-central-images-cdn.bioz.com/pub_med_central_ids_ending_with_6006/pmc12796006/pmc12796006__gr1.jpg)
